Results 81 to 90 of about 3,419 (164)

Évaluation d’un test de dépistage du syndrome VEXAS à partir de l’entrepôt de données biomédicales du CHU de Bordeaux. Application en Rhumatologie

open access: yes, 2023
Introduction: VEXAS syndrome is an acquired monogenic auto-inflammatory disease linked to a mutation in the UBA1 gene discovered in 2020. This disease, which has a poor prognosis in the absence of treatment, combines systemic autoinflammatory disorders ...
Hamon, Alexis
core  

Inappropriate Ras activation in the brains of E1 homozygous mutant.

open access: yes, 2013
Argos is a high threshold target of Ras signaling. Expression of argos can be monitored using an argos-lacZ reporter. Upon high Ras activation, lacZ is transcribed in the pattern of argos and the gene product can be detected using immunohistochemical ...
Hsiu-Yu Liu (286342)   +1 more
core   +1 more source

A clinical phenotype of VEXAS syndrome with pleural effusion, infiltrates, and systemic inflammation in a 76-year-old patient: a case report

open access: yesJournal of Medical Case Reports
Introduction VEXAS syndrome, characterized by a UBA1 gene mutation, is a rare and severe systemic inflammatory disease predominantly affecting men. Since its initial description in 2020, it has been noted for its broad clinical phenotype and frequent ...
Melanie Berger   +9 more
doaj   +1 more source

Síndrome VEXAS con vasculitis leucocitoclástica

open access: yes
VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic), first described in 2020, is a monogenic autoinflammatory disease caused by somatic mutations in the UBA1 gene, located on the X chromosomeand therefore predominantly expressed in ...
Trujillo-Aguilera, Antonio   +4 more
core   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

SF3B1-mutant models of RNA mis-splicing uncover UBA1 as a therapeutic target in myelodysplastic neoplasms

open access: yes
Myelodysplastic syndromes with somatic mutations in the splicing factor SF3B1 gene (MDS-SF3B1) result in RNA mis-splicing, erythroid dysplasia and ultimately refractory anemia.
Elli Papaemmanuil (6499196)   +16 more
core  

Navigating therapeutic challenges in VEXAS syndrome: exploring IL-6 and JAK inhibitors at the forefront

open access: yesMolecular Medicine
VEXAS syndrome, an uncommon yet severe autoimmune disorder stemming from a mutation in the UBA1 gene, is the focus of this paper. The overview encompasses its discovery, epidemiological traits, genetic underpinnings, and clinical presentations.
Xiao Xiao Li   +8 more
doaj   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Efficient enrichment of seamlessly gene-edited HSPCs by targeted integration into haploinsufficient genes.

open access: yes
reservedPreclinical data in mouse models and occurrence of adverse events in some clinical trials have shown that random integration of strong promoters by viral vectors can be unpredictably genotoxic.
RUSSO, DARIO
core  

VEXAS syndrome in rheumatology practice: features from a multicenter cohort in north-east Italy

open access: yesFrontiers in Immunology
ObjectiveVEXAS syndrome (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is a late-onset autoinflammatory disorder caused by somatic mutations in the UBA1 gene.
Sara Bindoli   +24 more
doaj   +1 more source

Home - About - Disclaimer - Privacy